Balyasny Asset Management »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.2M 4.0M 1.29
2023-12-31 $5.1M 5.0M 1.02

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Apple Call Option (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Select Sector Spdr Tr Financial (XLF)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Total Stk Mkt (VTI)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Mastercard Incorporated Cl A Call Option (MA)
Hess Call Option (HES)
Lockheed Martin Corporation Call Option (LMT)
Endeavor Group Hldgs Cl A Com Put Option (EDR)

View all positions for Balyasny Asset Management

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Ing Investment Management
Highbridge Capital Management
Calamos Advisors
Tenor Capital Management
Davidson Kempner Capital Management
Advent Capital Management
Steelhead Partners
Lazard Asset Management
BlackRock
Magnetar Financial
State Street Corporation
OZ Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Lord, Abbett & Co
Bnp Paribas Arbitrage, Snc

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1